José Manuel Mas

852 total citations
34 papers, 592 citations indexed

About

José Manuel Mas is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, José Manuel Mas has authored 34 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Immunology. Recurrent topics in José Manuel Mas's work include Protein Structure and Dynamics (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Enzyme Structure and Function (4 papers). José Manuel Mas is often cited by papers focused on Protein Structure and Dynamics (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Enzyme Structure and Function (4 papers). José Manuel Mas collaborates with scholars based in Spain, United States and Switzerland. José Manuel Mas's co-authors include Mireia Coma, Patrick Aloy, Francesc Avilés, Rafael de Llorens, Judith Farrés, Carmen Blanco‐Aparicio, Baldomero Oliva, Baldo Oliva, Miguel Ángel Molina‐Vila and Marsha L. Frazier and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Bioinformatics.

In The Last Decade

José Manuel Mas

33 papers receiving 576 citations

Peers

Countries citing papers authored by José Manuel Mas

Since Specialization

Citations

This map shows the geographic impact of José Manuel Mas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Manuel Mas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Manuel Mas more than expected).

Fields of papers citing papers by José Manuel Mas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Manuel Mas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Manuel Mas. The network helps show where José Manuel Mas may publish in the future.

Co-authorship network of co-authors of José Manuel Mas

This figure shows the co-authorship network connecting the top 25 collaborators of José Manuel Mas. A scholar is included among the top collaborators of José Manuel Mas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Manuel Mas. José Manuel Mas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A decision support system based on artificial intelligence and systems biology for the simulation of pancreatic cancer patient status 2023 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), (unknown), (unknown), (unknown), Baldo Oliva, Judith Farrés, Xavier Daura, José Manuel Mas, (unknown)	4
2	A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis 2023 ·Frontiers in Immunology ·Pablo Coto‐Segura, (unknown), Antonio Martorell, D. Moreno‐Ramírez, (unknown), (unknown), (unknown), Xavier Daura, Baldomero Oliva, (unknown), (unknown), Sonya Abraham, José Manuel Mas	4
3	Female Sex, Age, and Unfavorable Response to Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis: Results of Statistical and Artificial Intelligence–Based Data Analyses of a National Multicenter Prospective Registry 2022 ·Arthritis Care & Research ·Cristina Fernández‐Carballido, Carlos Sánchez‐Piedra, (unknown), (unknown), Fernando Sánchez‐Alonso, (unknown), José Manuel Mas, Vega Jovaní, Sara Manrique‐Arija, Cristina Campos, Mercedes Freire, Olga Martínez González, Isabel Castrejón, Chiara Perella, Mireia Coma, Irene E. van der Horst‐Bruinsma	11
4	CuBlock: a cross-platform normalization method for gene-expression microarrays 2021 ·Bioinformatics ·(unknown), Judith Farrés, José Manuel Mas, Xavier Daura	7
5	Identification of the most vulnerable populations in the psychosocial sphere: a cross-sectional study conducted in Catalonia during the strict lockdown imposed against the COVID-19 pandemic 2021 ·BMJ Open ·Judith Farrés, (unknown), José Manuel Mas, (unknown), Maria‐Rosa Sarrias, Carolina Armengol, Père-Joan Cardona, José A. Muñoz-Moreno, (unknown), Belén Arranz, Judith Usall, Antoni Serrano‐Blanco, Cristina Vilaplana	5
6	Methods to Develop an in silico Clinical Trial: Computational Head-to-Head Comparison of Lisdexamfetamine and Methylphenidate 2021 ·Frontiers in Psychiatry ·(unknown), Javier Quintero, (unknown), (unknown), Vicente Martínez, (unknown), Baldomero Oliva, Xavier Daura, José Manuel Mas, (unknown)	14
7	Proteomics based drug repositioning applied to improve in vitro fertilization implantation: an artificial intelligence model 2021 ·Systems Biology in Reproductive Medicine ·Roberto Matorras, (unknown), Mikel Azkargorta, Jorge Burgos, (unknown), Félix Elortza, José Manuel Mas, Teresa Sardón	1
8	Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia 2020 ·Scientific Reports ·(unknown), (unknown), (unknown), Laia Rosich, Mònica López‐Guerra, Irene López‐Oreja, (unknown), Fabián Arenas, José Manuel Mas, Patricia Pérez‐Galán, Julio Delgado, Elı́as Campo, Judith Farrés, Dolors Colomer	24
9	In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm 2020 ·PLoS ONE ·(unknown), Mireia Coma, (unknown), (unknown), Judith Farrés, (unknown), Narcís Fernández‐Fuentes, Juan de la Haba-Rodríguez, Àlex Olvera, (unknown), (unknown), Baldo Oliva, José Manuel Mas	58
10	In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan 2020 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), José Luis Ruiz, (unknown), Narcís Fernández‐Fuentes, José Manuel Mas, Baldo Oliva	33
11	Aging Increases Hippocampal DUSP2 by a Membrane Cholesterol Loss-Mediated RTK/p38MAPK Activation Mechanism 2019 ·Frontiers in Neurology ·Adrián Martín‐Segura, (unknown), Pietro Fazzari, José Manuel Mas, (unknown), (unknown), Ángel R. Nebreda, Carlos G. Dotti	4
12	Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival 2018 ·Liver International ·Cristina Solé, Elsa Solà, Patrícia Huelin, Marta Carol, Rebeca Moreira, (unknown), José Manuel Mas, Isabel Graupera, Elisa Pose, Laura Napoleone, (unknown), Adrià Juanola, Núria Fabrellas, Ferràn Torres, Manuel Morales‐Ruiz, Judith Farrés, Wladimiro Jiménez, Pere Ginès	54
13	Neuroprotective Drug for Nerve Trauma Revealed Using Artificial Intelligence 2018 ·Scientific Reports ·(unknown), Joaquím Forés, Mireia Herrando‐Grabulosa, (unknown), (unknown), Elena Galea, Francisco González, Xavier Navarro, Valérie Petegnief, Assumpció Bosch, Mireia Coma, José Manuel Mas, Caty Casas	51
14	Novel Neuroprotective Multicomponent Therapy for Amyotrophic Lateral Sclerosis Designed by Networked Systems 2016 ·PLoS ONE ·Mireia Herrando‐Grabulosa, Roger Mulet‐Lazaro, (unknown), José Manuel Mas, Xavier Navarro, Patrick Aloy, Mireia Coma, Caty Casas	25
15	Methods for diagnosing perceived age on the basis of an ensemble of phenotypic features 2014 ·Clinical Cosmetic and Investigational Dermatology ·(unknown), Mireia Coma, (unknown), José Manuel Mas, (unknown), (unknown), (unknown)	27
16	Towards a molecular characterisation of pathological pathways 2008 ·FEBS Letters ·Roland A. Pache, Andreas Zanzoni, (unknown), José Manuel Mas, Patrick Aloy	30
17	Classification of protein disulphide-bridge topologies 2001 ·Journal of Computer-Aided Molecular Design ·José Manuel Mas, Patrick Aloy, Marc A. Martı́-Renom, Baldomero Oliva, Rafael de Llorens, Francesc Avilés, Enrique Querol	16
18	Refinement of modelled structures by knowledge-based energy profiles and secondary structure prediction: Application to the human procarboxypeptidase A2 2000 ·Journal of Computer-Aided Molecular Design ·Patrick Aloy, José Manuel Mas, Marc A. Martı́-Renom, (unknown), Francesc Avilés, Baldomero Oliva	6
19	Protein similarities beyond disulphide bridge topology 1998 ·Journal of Molecular Biology ·José Manuel Mas, Patrick Aloy, Marc A. Martı́-Renom, Baldomero Oliva, Carmen Blanco‐Aparicio, (unknown), Rafael de Llorens, Enrique Querol, Francesc Avilés	31
20	Potato Carboxypeptidase Inhibitor, a T-knot Protein, Is an Epidermal Growth Factor Antagonist That Inhibits Tumor Cell Growth 1998 ·Journal of Biological Chemistry ·Carmen Blanco‐Aparicio, Miguel Ángel Molina‐Vila, Ester Fernández‐Salas, Marsha L. Frazier, José Manuel Mas, (unknown), Francesc Avilés, Rafael de Llorens	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact